Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Public Health topic
No spam. Unsubscribe anytime.
Committee forwards DPH amendment to expand syringe access, naloxone and fentanyl test strip services
Summary
The committee forwarded a resolution to amend the San Francisco AIDS Foundation contract to increase funding roughly $6.5 million (total not to exceed ~$42.1M) through June 30, 2026 to expand syringe access, testing, naloxone distribution and linkage to care.
The Budget and Finance Committee voted Nov. 17 to forward a Department of Public Health request to amend its agreement with the San Francisco AIDS Foundation to expand citywide syringe access and disposal services. The amendment (Amendment No. 3) would increase the contract by about $6.5 million for a total not to exceed approximately $42.1 million, with no change to the existing term (through 06/30/2026).
Tracy Packer, director of the Community Health Equity and Promotion branch at DPH, explained the amendment builds on ongoing services to reduce HIV and hepatitis C disparities among people who use drugs, including expanded testing, treatment linkage, distribution of sterile injection equipment, naloxone, fentanyl‑test strips and low‑barrier treatment referrals. Nicole Trainer, DPH contract manager, said funded programs have already deployed outreach staff, naloxone wall mounts at clinics and bilingual staffing to reach impacted neighborhoods like the Tenderloin and Mission.
The BLA confirmed there was no updated report for the item, and the committee approved forwarding the amendment to the full Board with a positive recommendation.
Why it matters: The amendment increases the city’s investment in harm‑reduction infrastructure aimed at reducing HIV, hepatitis C and fatal overdoses in communities most affected by substance use disorder and housing instability.
